Manganese produce a parkinsonism-like illness characterized by movement abnormalities. This condition is not responsive to typical therapies used in the treatment of PD, suggesting an alternative pathway than the typical dopaminergic loss within the substantia nigra. Manganese may accumulate in the basal ganglia, leading to the abnormal movements. A mutation of the SLC30A10 gene, a manganese efflux transporter necessary for decreasing intracellular Mn, has been linked with the development of this Parkinsonism-like disease. The Lewy bodies typical to PD are not seen in Mn-induced parkinsonism. Animal experiments have given the opportunity to examine the consequences of manganese overexposure under controlled conditions.
Manganese white magnesia alba (magnesium oxide), which provided the name magnesium for the free element when it was isolated much later. Several colorful oxides of manganese, for example manganese dioxide, are abundant in nature and have been used as pigments since the Stone Age. The cave paintings in Gargas that are 30,000 to 24,000 years old contain manganese pigments. Manganese compounds were used by Egyptian and Roman glassmakers, either to add to, or remove color from glass. Use as "glassmakers soap" continued through the Middle Ages until modern times and is evident in 14th-century glass from Venice. Because it was used